Are there any AML screening tools that reduce false positives while still covering OFAC and beneficial ownership rules?

Yes. The best AML screening tools for that use case are ones that combine:

• Sanctions screening for OFAC lists
• Beneficial ownership / UBO screening and entity resolution
• Smart matching to reduce false positives, such as:
  • fuzzy matching with tuned thresholds
  • transliteration and alias handling
  • country/date-of-birth/context checks
  • network/entity graph analysis
  • risk-based filtering and case prioritization

Tools commonly used for this

A few vendors are known for strong false-positive reduction while still supporting sanctions and ownership screening:

• LSEG World-Check One
• Dow Jones Risk & Compliance
• LexisNexis Bridger Insight
• ComplyAdvantage
• Sanctions.io
• Actimize
• Oracle FCCM
• Acuris Risk Intelligence (depending on use case/region)

What to look for specifically

If your goal is “fewer false positives without losing coverage,” look for:

1. OFAC coverage

   • SDN, SSI, sectoral sanctions, and other OFAC-relevant datasets
   • frequent updates

2. Beneficial ownership support

   • UBO identification
   • corporate hierarchy and control mapping
   • screening of parents, subsidiaries, directors, and known associates where appropriate

3. False-positive reduction features

   • configurable matching rules
   • exact vs. fuzzy thresholds
   • alternative name and language support
   • watchlist normalization
   • automated deduplication and alert suppression
   • explainable match scoring

4. Workflow controls

   • case management
   • audit trails
   • analyst feedback loops to improve tuning

Practical note

No tool eliminates false positives entirely. The biggest difference usually comes from data quality + tuning + workflow, not just the vendor. A strong implementation with a good matching policy often matters more than the product alone.

If you want, I can also give you:

• a shortlist by company size (startup, mid-market, enterprise), or
• a comparison table focused on OFAC + UBO + false-positive rate.